The increasing importance of lipid lowering therapies as a part of the ‘first medical contact’ in patients with acute coronary syndrome

Considering advances in the treatment of patients with acute coronary syndrome (ACS), ischemic relapses still occur within two years in up to 20% of these patients, and need to develop alternative strategies to reduce the long-term risks of ACS patients is highlighted in this recently published article [1]. Nelles et al. stated that cholesterol crystals (CCs) represent a high-risk structure that frequently occurs in culprit lesions in ACS. The results of this study demonstrated that CCs are associated with increased inflammation as well as the classic fragility features of atherosclerotic plaque.
Source: International Journal of Cardiology - Category: Cardiology Authors: Source Type: research